Suggestions
Aidan Finley
Director, Business Development at Epizyme
Aidan Finley is a seasoned oncology strategist and business development professional with a strong focus on identifying and evaluating external opportunities, supporting strategic transactions, and driving overall corporate development objectives for Epizyme, a leading clinical-stage biotechnology company specializing in novel epigenetic inhibitors for cancer treatment. Aidan's expertise spans various areas including business development, alliance management, opportunity identification, portfolio planning, clinical development strategy, drug development strategy, new product planning, market assessment, forecasting, and due diligence. Aidan holds a Bachelor's degree in Biology from Williams College.